The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Aadi Bioscience Inc | Common | 00032Q104 | 1,029,335 | 509,572 | SH | SOLE | 509,572 | 0 | 0 | |||
| Alpine Immune Sciences Inc | Common | 02083G100 | 15,615,382 | 819,275 | SH | SOLE | 819,275 | 0 | 0 | |||
| Aligos Therapeutics Inc | Common | 01626L105 | 2,355,228 | 3,547,030 | SH | SOLE | 3,547,030 | 0 | 0 | |||
| Allakos Inc | Common | 01671P100 | 8,157,240 | 2,988,000 | SH | SOLE | 2,988,000 | 0 | 0 | |||
| ALX Oncology Holdings Inc | Common | 00166B105 | 62,836,515 | 4,220,048 | SH | SOLE | 4,220,048 | 0 | 0 | |||
| Apogee Therapeutics Inc | Common | 03770N101 | 11,176,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | |||
| Arrowhead Pharmaceuticals Inc | Common | 04280A100 | 4,204,777 | 137,411 | SH | SOLE | 137,411 | 0 | 0 | |||
| Astria Therapeutics Inc | Common | 04635X102 | 19,067,343 | 2,482,727 | SH | SOLE | 2,482,727 | 0 | 0 | |||
| Avadel Pharmaceuticals PLC | ADR | 05337M104 | 57,841,563 | 4,096,428 | SH | SOLE | 4,096,428 | 0 | 0 | |||
| Bolt Therapeutics Inc | Common | 097702104 | 3,943,846 | 3,521,291 | SH | SOLE | 3,521,291 | 0 | 0 | |||
| Codexis, Inc | Common | 192005106 | 1,183,839 | 388,144 | SH | SOLE | 388,144 | 0 | 0 | |||
| Cogent Biosciences Inc | Common | 19240Q201 | 13,200,253 | 2,244,941 | SH | SOLE | 2,244,941 | 0 | 0 | |||
| Compass Pathway PLC | SPONSORED ADS | 20451W101 | 14,070,000 | 1,608,000 | SH | SOLE | 1,608,000 | 0 | 0 | |||
| Compass Therapeutics Inc | Common | 20454B104 | 5,547,396 | 3,556,023 | SH | SOLE | 3,556,023 | 0 | 0 | |||
| Crinetics Pharmaceuticals Inc | Common | 22663K107 | 12,453,000 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | |||
| DBV Technologies SA | SPONSORED ADS | 23306J101 | 2,581,016 | 2,708,875 | SH | SOLE | 2,708,875 | 0 | 0 | |||
| Delcath Systems, Inc. | Common | 24661P807 | 3,557,595 | 855,191 | SH | SOLE | 855,191 | 0 | 0 | |||
| Dyne Therapeutics Inc | Common | 26818M108 | 13,767,309 | 1,035,136 | SH | SOLE | 1,035,136 | 0 | 0 | |||
| Engene Holdings Inc. | Common | 29286M105 | 6,264,447 | 678,705 | SH | SOLE | 678,705 | 0 | 0 | |||
| Genetron Holdings Ltd | ADS | 37186H209 | 9,965,646 | 2,708,056 | SH | SOLE | 2,708,056 | 0 | 0 | |||
| Geron Corp | Common | 374163103 | 50,943,167 | 24,143,681 | SH | SOLE | 24,143,681 | 0 | 0 | |||
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | 95,846,709 | 9,546,485 | SH | SOLE | 9,546,485 | 0 | 0 | |||
| Harmony Biosciences Holdings Inc | Common | 413197104 | 84,181,778 | 2,606,247 | SH | SOLE | 2,606,247 | 0 | 0 | |||
| Homology Medicines, Inc. | Common | 438083107 | 225,001 | 370,068 | SH | SOLE | 370,068 | 0 | 0 | |||
| Icosavax, Inc. | Common | 45114M109 | 26,863,992 | 1,704,568 | SH | SOLE | 1,704,568 | 0 | 0 | |||
| Instil Bio Inc | Common | 45783C200 | 4,757,471 | 624,340 | SH | SOLE | 624,340 | 0 | 0 | |||
| IO Biotech Inc | Common | 449778109 | 11,606,065 | 6,173,439 | SH | SOLE | 6,173,439 | 0 | 0 | |||
| Iovance Biotherapeutics Inc | Common | 462260100 | 5,325,613 | 655,057 | SH | SOLE | 655,057 | 0 | 0 | |||
| KalVista Pharmaceuticals Inc. | Common | 483497103 | 10,486,098 | 856,008 | SH | SOLE | 856,008 | 0 | 0 | |||
| Olema Pharmaceuticals Inc | Common | 68062P106 | 26,288,067 | 1,873,704 | SH | SOLE | 1,873,704 | 0 | 0 | |||
| Oric Pharmaceuticals Inc | Common | 68622P109 | 7,817,065 | 849,681 | SH | SOLE | 849,681 | 0 | 0 | |||
| Pharvaris NV | Common | N69605108 | 7,994,250 | 285,000 | SH | SOLE | 285,000 | 0 | 0 | |||
| Precision Biosciences Inc | Common | 74019P108 | 51,193 | 140,255 | SH | SOLE | 140,255 | 0 | 0 | |||
| Rayzebio Inc | Common | 75525N107 | 6,874,821 | 110,581 | SH | SOLE | 110,581 | 0 | 0 | |||
| Rezolute Inc | Common | 76200L309 | 3,218,521 | 3,242,842 | SH | SOLE | 3,242,842 | 0 | 0 | |||
| Savara Inc | Common | 805111101 | 9,815,118 | 2,088,323 | SH | SOLE | 2,088,323 | 0 | 0 | |||
| Sera Prognostics Inc | Common | 81749D107 | 9,869,631 | 1,650,440 | SH | SOLE | 1,650,440 | 0 | 0 | |||
| Silence Therapeutics PLC | ADS | 82686Q101 | 8,862,243 | 510,204 | SH | SOLE | 510,204 | 0 | 0 | |||
| Soleno Therapeutics Inc | Common | 834203309 | 338,828,243 | 8,418,093 | SH | SOLE | 8,418,093 | 0 | 0 | |||
| Tarsus Pharmaceuticals Inc | Common | 87650L103 | 36,126,122 | 1,784,006 | SH | SOLE | 1,784,006 | 0 | 0 | |||
| Terns Pharmaceuticals Inc | Common | 880881107 | 43,210,368 | 6,657,992 | SH | SOLE | 6,657,992 | 0 | 0 | |||
| Tourmaline Bio Inc. | Common | 89157D105 | 15,495,471 | 591,882 | SH | SOLE | 591,882 | 0 | 0 | |||
| Unicycive Therapeutics | Common | 90466Y103 | 3,011,051 | 3,470,152 | SH | SOLE | 3,470,152 | 0 | 0 | |||
| Verastem Inc | Common | 92337C203 | 12,523,073 | 1,538,461 | SH | SOLE | 1,538,461 | 0 | 0 | |||
| Verona Pharma PLC | SPONSORED ADS | 925050106 | 84,488,370 | 4,249,918 | SH | SOLE | 4,249,918 | 0 | 0 | |||
| Viridian Therapeutics Inc | Common | 92790C104 | 36,551,348 | 1,678,207 | SH | SOLE | 1,678,207 | 0 | 0 | |||
| Zai Lab Ltd | ADR | 98887Q104 | 11,251,132 | 411,677 | SH | SOLE | 411,677 | 0 | 0 | |||